Repair Biotechnologies, Inc. is a biotechnology company with the mission to develop and bring to the clinic therapies that significantly improve human healthspan through targeting the causes of age-related diseases and aging itself. Founded in 2018, Repair Biotechnologies is developing therapies with the goals of regenerating the thymus, treating cancer, and reversing atherosclerosis.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/07/19 | $2,150,000 | Seed |
Emerging Longevity Ventures Jim Mellon  SENS Research Foundation Thynk Capital | undisclosed |
